Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in CRMD — CorMedix Inc.

CIK 19617 NEW YORK, NY
Back to CRMD Full portfolio

Position in CRMD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$529,205
-$258,161 QoQ
Shares Held
67,415
-41.9% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 194 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 54% Shared 0% None 46%

Common Shares in CRMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. CRMD ranks #197 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in CRMD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $529,205 67,415
2026-03-31 $787,366 115,960
2025-12-31 $1,253,340 107,768
2025-09-30 $1,130,759 97,228
2025-06-30 $432,960 35,143
2025-03-31 $223,218 36,237
2024-12-31 $2,213,064 273,218
2024-09-30 $1,568,392 194,108
2024-06-30 $106,997 24,711
2024-03-31 $94,313 22,244
2023-12-31 $141,845 37,725
2023-09-30 $127,904 34,569
2023-06-30 $232,951 58,678
2022-12-31 $1 195
2022-09-30 $61,079 21,583
2022-06-30 $317,068 78,873
2022-03-31 $221,621 40,442
2021-12-31 $175,056 38,474
2021-09-30 $125,940 27,084
2021-06-30 $346,038 50,443
2021-03-31 $582,874 58,346
2020-12-31 $636,891 85,719
2020-09-30 $173,796 28,822
2020-06-30 $87,972 13,964
2020-03-31 $29,312 8,165